|
synaptic signaling via neuropeptide
|
GO_0099538 |
[Cell-cell signaling to or from a synapse, mediated by a peptide.] |
|
EC 3.* (hydrolase) inhibitor
|
CHEBI_76759 |
[Any enzyme inhibitor that interferes with the action of a hydrolase (EC 3.*.*.*).] |
|
enzyme inhibitor
|
CHEBI_23924 |
[A compound or agent that combines with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction.] |
|
EC 3.5.* (hydrolases acting on non-peptide C-N bonds) inhibitor
|
CHEBI_76764 |
[Any hydrolase inhibitor that interferes with the action of a hydrolase acting on C-N bonds, other than peptide bonds (EC 3.5.*.*).] |
|
protein catabolic process, modulating synaptic transmission
|
GO_0099546 |
[Any protein degradation process, occurring at a presynapse, that regulates synaptic transmission.] |
|
T-cell-specific surface glycoprotein CD28 (mouse)
|
PR_P31041 |
[A T-cell-specific surface glycoprotein CD28 that is encoded in the genome of mouse.] |
|
regulation of hepatic stellate cell activation
|
GO_2000489 |
[Any process that modulates the frequency, rate or extent of hepatic stellate cell activation.] |
|
positive regulation of antigen processing and presentation of peptide antigen via MHC class I
|
GO_0002591 |
[Any process that activates or increases the frequency, rate, or extent of antigen processing and presentation of peptide antigen via MHC class I.] |
|
regulation of antigen processing and presentation of peptide antigen via MHC class I
|
GO_0002589 |
[Any process that modulates the frequency, rate, or extent of antigen processing and presentation of peptide antigen via MHC class I.] |
|
positive regulation of antigen processing and presentation of peptide antigen
|
GO_0002585 |
[Any process that activates or increases the frequency, rate, or extent of antigen processing and presentation of peptide antigen.] |
|
negative regulation of antigen processing and presentation of peptide antigen via MHC class I
|
GO_0002590 |
[Any process that stops, prevents, or reduces the frequency, rate, or extent of antigen processing and presentation of peptide antigen via MHC class I.] |
|
negative regulation of antigen processing and presentation of peptide antigen
|
GO_0002584 |
[Any process that stops, prevents, or reduces the frequency, rate, or extent of antigen processing and presentation of peptide antigen.] |
|
regulation of cell proliferation involved in compound eye morphogenesis
|
GO_2000495 |
[Any process that modulates the frequency, rate or extent of cell proliferation involved in compound eye morphogenesis.] |
|
negative regulation of cell proliferation involved in compound eye morphogenesis
|
GO_2000496 |
[Any process that stops, prevents or reduces the frequency, rate or extent of cell proliferation involved in compound eye morphogenesis.] |
|
positive regulation of cell proliferation involved in compound eye morphogenesis
|
GO_2000497 |
[Any process that activates or increases the frequency, rate or extent of cell proliferation involved in compound eye morphogenesis.] |
|
negative regulation of hepatic stellate cell activation
|
GO_2000490 |
[Any process that stops, prevents or reduces the frequency, rate or extent of hepatic stellate cell activation.] |
|
positive regulation of hepatic stellate cell activation
|
GO_2000491 |
[Any process that activates or increases the frequency, rate or extent of hepatic stellate cell activation.] |
|
tachykinin-3 (mouse)
|
PR_P55099 |
[A tachykinin-3 that is encoded in the genome of mouse.] |
|
regulation of antigen processing and presentation of peptide antigen
|
GO_0002583 |
[Any process that modulates the frequency, rate, or extent of antigen processing and presentation of peptide antigen.] |
|
positive regulation of antigen processing and presentation of peptide antigen via MHC class II
|
GO_0002588 |
[Any process that activates or increases the frequency, rate, or extent of antigen processing and presentation of peptide antigen via MHC class II.] |